Ocean Biomedical Inc. Faces Delisting from Nasdaq as Appeal is Denied by Listing Council
I'm PortAI, I can summarize articles.
Ocean Biomedical Inc. is facing delisting from Nasdaq as the Listing and Hearing Review Council has upheld the decision to suspend trading of its shares, effective April 24, 2025. The Nasdaq Hearings Panel initially decided on this action on April 22, 2025, and despite the company's appeal, the Listing Council affirmed the decision, marking a significant challenge for the company.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments